Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Canoderm and Oviderm for Diabetic Foot Xerosis
NCT06427889Phase 4Recruiting
- Sponsor
- Malmö University
- Start
- Sep 2024
- Primary completion
- Nov 2025
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Canoderm, propylene glycol in xerosis, sponsored by Malmö University. Started Sep 2024; status: recruiting.
02
Drugs
Canodermpropylene glycol
03
Conditions
xerosis
Beyond the preview
Go deeper on NCT06427889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06427889.